Changes in the prevalence of psychological distress and use of antidepressants or anti-anxiety medications associated with comorbid chronic diseases in the adult Australian population, 2001-2008

Australian and New Zealand Journal of Psychiatry

Volumn 46, Issue 5, 2012, Pages 445-456

  Atlantis, Evan ^a,b   Sullivan, Thomas ^b   Sartorius, Norman ^c   Almeida, Osvaldo P ^d,e  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c Association for the Improvement of Mental Health Programmes   (Switzerland)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e ROYAL PERTH HOSPITAL   (Australia)

Author keywords

anti anxiety medications; antidepressants; anxiety; chronic disease; depression; Psychological distress; trends

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT;

ADULT; AGED; ANGINA PECTORIS; ARTERIOSCLEROSIS; ARTICLE; ASTHMA; ATHEROSCLEROSIS; AUSTRALIA; BASAL CELL CARCINOMA; BLADDER CANCER; BREAST CANCER; BRONCHUS CANCER; CANCER OF UNKNOWN PRIMARY SITE; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; COLORECTAL CANCER; COMORBIDITY; DISTRESS SYNDROME; EDEMA; FEMALE; GOUT; HEALTH SURVEY; HEART FAILURE; HEART INFARCTION; HEART MURMUR; HEART PALPITATION; HEMORRHOID; HUMAN; HYPERTENSION; HYPOTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY CANCER; LEUKEMIA; LIFESTYLE; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOARTHRITIS; OVARY CANCER; PLEURA CANCER; PREDICTOR VARIABLE; PREVALENCE; PROSTATE CANCER; RHEUMATIC HEART DISEASE; RHEUMATOID ARTHRITIS; SELF REPORT; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; TACHYCARDIA; TRACHEA CANCER; UTERINE CERVIX CANCER; UTERUS CANCER; VALVULAR HEART DISEASE; VARICOSIS; MENTAL STRESS; MIDDLE AGED;

ADULT; AGED; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; AUSTRALIA; CHRONIC DISEASE; COMORBIDITY; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; STRESS, PSYCHOLOGICAL;

EID: 84865299496     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867411433218     Document Type: Article

References (47)

1. Andrews G, Slade T. Interpreting scores on the Kessler Psychological Distress Scale (K10). Australian and New Zealand Journal of Public Health. 2001 ; 25: 494-497 (Pubitemid 34044202)
2. Atlantis E, Ball K. Association between weight perception and psychological distress. International Journal of Obesity. 2008 ; 32: 715-721 (Pubitemid 351536010)
3. Atlantis E, Lange K, Wittert GA. Chronic disease trends due to excess body weight in Australia. Obesity Reviews. 2009 ; 10: 543-553
4. Atlantis E, Shi Z, Penninx BJ, et al. Chronic medical conditions mediate the association between depression and cardiovascular disease mortality. Social Psychiatry and Psychiatric Epidemiology. 2011a 2011 ;:
5. Atlantis E, Goldney RD, Eckert KA, et al. Trends in health-related quality of life and health service use associated with comorbid diabetes and major depression in South Australia, 1998-2008. Social Psychiatry and Psychiatric Epidemiology. 2011b 2011 ;:
6. Atlantis E, Lange K, Goldney RD, et al. Specific medical conditions associated with clinically significant depressive symptoms in men. Social Psychiatry and Psychiatric Epidemiology. 2011c ; 46: 1303-1312
7. Catalogue No. 4359.0 - How Australian Measure Up, 1995. Canberra: Australian Bureau of Statistics ; 1998 :
8. Australian Bureau of Statistics a. National Health Survey:2001. Authorised accessed via basic CD-ROM. Confidentialised Unit Record File No: 990
9. Australian Bureau of Statistics b. National Health Survey:2005. Authorised accessed via basic CD-ROM. Confidentialised Unit Record File No: 1778.
10. Australian Bureau of Statistics c. National Health Survey: 2007-08. Authorised accessed via basic CD-ROM. Confidentialised Unit Record File No: 4324.
11. Catalogue No. 4326.0. 2007 National Survey of Mental Health and Wellbeing: Summary of results. Canberra: Australian Bureau of Statistics ; 2008 :
12. Barbui C, Campomori A, D'Avanzo B, et al. Antidepressant drug use in Italy since the introduction of SSRIs: national trends, regional differences and impact on suicide rates. Social Psychiatry and Psychiatric Epidemiology. 1999 ; 34: 152-156 (Pubitemid 29213846)
13. Brhlikova P, Pollock AM, Manners R.. Global burden of disease estimates of depression - how reliable is the epidemiological evidence?. Journal of the Royal Society of Medicine. 2011 ; 104: 25-34
14. Britt HC, Harrison CM, Miller GC, et al. Prevalence and patterns of multimorbidity in Australia. Medical Journal of Australia. 2008 ; 189: 72-77
15. Caughey GE, Roughead EE, Shakib S, et al. Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants. Age and Ageing. 2010 ; 39: 488-494
16. Clarke DM, Currie KC. Depression, anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence. Medical Journal of Australia. 2009 ; 190: S54-60
17. Coles-Rutishauser I, Webb K, Abraham BL, et al Evaluation of short dietary questions from the 1995 National Nutrition Survey. Brisbane: Australian Food and Nutrition Monitoring Unit, The University of Queensland ; 2001 :
18. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011a ; 378: 31-40
19. Danaei G, Finucane MM, Lin JK, et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants. Lancet. 2011b ; 377: 568-577
20. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine. 2000 ; 160: 2101-2107 (Pubitemid 30482715)
21. Dunstan DW, Zimmet PZ, Welborn TA, et al Diabesity & Associated Disorders in Australia -2000. The Accelerating Epidemic. Melbourne: International Diabetes Institute ; 2001 :
22. Egede LE. Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability. General Hospital Psychiatry. 2007 ; 29: 409-416 (Pubitemid 47410305)
23. Farzadfar F, Finucane MM, Danaei G, et al. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants. Lancet. 2011 ; 377: 578-586
24. Fletcher JR, Bassilios B, Kohn F, et al. Meeting demand for psychological services for people with depression and anxiety: recent developments in primary mental health care. Medical Journal of Australia. 2008 ; 188: S107-109
25. Goldney RD, Eckert KA, Hawthorne G, et al. Changes in the prevalence of major depression in an Australian community sample between 1998 and 2008. Australian and New Zealand Journal of Psychiatry. 2010 ; 44: 901-910
26. Grayson DA, Mackinnon A, Jorm AF, et al. Item bias in the Center for Epidemiologic Studies Depression Scale: effects of physical disorders and disability in an elderly community sample. Journals of Gerontology Series B: Psychological Sciences and Social Sciences. 2000 ; 55: P273-282
27. Gunn JM, Ayton DR, Densley K, et al. The association between chronic illness, multimorbidity and depressive symptoms in an Australian primary care cohort. Social Psychiatry and Psychiatric Epidemiology. 2010 ; 47: 175-184
28. Psychiatric Services. Harman JS Edlund MJ Fortney JC, ed. 2009: 611-616.
29. Harris MG, Burgess PM, Pirkis J, et al. Correlates of antidepressant and anxiolytic, hypnotic or sedative medication use in an Australian community sample. Australian and New Zealand Journal of Psychiatry. 2011 ; 45: 249-260
30. Holden L, Scuffham P, Hilton M, et al. Psychological distress is associated with a range of high-priority health conditions affecting working Australians. Australian and New Zealand Journal of Public Health. 2010 ; 34: 304-310
31. Hollingworth SA, Burgess PM, Whiteford HA. Affective and anxiety disorders: prevalence, treatment and antidepressant medication use. Australian and New Zealand Journal of Psychiatry. 2010 ; 44: 513-519
32. Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. General Hospital Psychiatry. 2007 ; 29: 147-155
33. Kessler RC, Andrews G, Colpe LJ, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychological Medicine. 2002 ; 32: 959-976
34. Kirsch I, Deacon BJ, Huedo-Medina TB, et al. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Medicine. 2008 ; 5: e45
35. Kosidou K, Magnusson C, Mittendorfer-Rutz E, et al. Recent time trends in levels of self-reported anxiety, mental health service use and suicidal behaviour in Stockholm. Acta Psychiatrica Scandinavica. 2010 ; 122: 47-55
36. Licht CM, de Geus EJ, Zitman FG, et al. Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). Archives of General Psychiatry. 2008 ; 65: 1358-1367
37. Mant A, Rendle VA, Hall WD, et al. Making new choices about antidepressants in Australia: the long view 1975-2002. Medical Journal of Australia. 2004 ; 181: S21-24
38. Mathew SJ, Charney DS. Publication bias and the efficacy of antidepressants. American Journal of Psychiatry. 2009 ; 166: 140-145
39. Meijer WE, Heerdink ER, Leufkens HG, et al. Incidence and determinants of long-term use of antidepressants. European Journal of Clinical Pharmacology. 2004 ; 60: 57-61 (Pubitemid 38471459)
40. Moore M, Yuen HM, Dunn N, et al. Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. BMJ. 2009 ; 339: b3999
41. Moussavi S, Chatterji S, Verdes E, et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007 ; 370: 851-858 (Pubitemid 47362344)
42. Olfson M, Marcus SC, Druss BG. Effects of Food and Drug Administration warnings on antidepressant use in a national sample. Archives of General Psychiatry. 2008 ; 65: 94-101
43. Olfson M, Marcus SC, Wan GJ, et al. National trends in the outpatient treatment of anxiety disorders. Journal of Clinical Psychiatry. 2004 ; 65: 1166-1173
44. Taylor D, Meader N, Bird V, et al. Pharmacological interventions for people with depression and chronic physical health problems: systematic review and meta-analyses of safety and efficacy. British Journal of Psychiatry. 2011 ; 198: 179-188
45. Turner EH, Matthews AM, Linardatos E, et al. Selective publication of antidepressant trials and its influence on apparent efficacy. New England Journal of Medicine. 2008 ; 358: 252-260
46. Uijen AA, van de, Lisdonk EH. Multimorbidity in primary care: prevalence and trend over the last 20 years. European Journal of General Practice. 2008 ; 14: 28-32
47. The Global Burden of Disease: 2004 Update. Geneva: WHO ; 2008 :